Whalegun
Home

Helen M. Thackray, Chief R&D Officer: Biocryst Pharmaceuticals BCRX Buy · Filed 24/05/15

Trade details

Type
Insider buy
Amount
$175,800
Shares · price
30,000 sh · $5.86 a share
Held after
272,139 sh
Stock
Biocryst Pharmaceuticals BCRX
Person
Helen M. ThackrayChief R&D Officer
Trade date
24/05/14
Filed
24/05/15
Days to filing
1 days

First buy since 2023

Insiders buying this week
8 insiders
Holding change
+12.4%

Biocryst Pharmaceuticals trades, last 26 weeks

What else happened in Biocryst Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/04/14~24/06/13

Helen M. Thackray's recent trades

  • Helen M. Thackray

    Planned saleBiocryst Pharmaceuticals

    $328K

    Filed 25/11/25

  • Helen M. Thackray

    Planned saleBiocryst Pharmaceuticals

    $307.7K

    Filed 25/11/21

  • Helen M. Thackray

    Sell10b5-1 planBiocryst Pharmaceuticals

    $58K

    Filed 23/04/05